The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

Complex, chronic illness experts discuss what GLP-1 agonists can and can't do in diseases like ME/CFS, long COVID, and POTS. Plus new long COVID trials.
Decoding ME: Big Stakes Genetics Study Puts ME/CFS on Firm Biological Foundation

Decoding ME: Big Stakes Genetics Study Puts ME/CFS on Firm Biological Foundation

The DecodeME study puts ME/CFS on a firm biological foundation by highlighting genes that play a prominent role in the brain, the immune system and metabolism.
An Explosion of ME/CFS in the US + The Real Difference RECOVER May Make In Long COVID

An Explosion of ME/CFS in the US + The Real Difference RECOVER May Make In Long COVID

Long COVID increases the prevalence of ME/CFS in the US fifteenfold plus a deep dive into RECOVER's testing program suggests it might help a lot.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest